We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688472:SSECSI Solar Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥14.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CSI Solar is trading at CNY 14.95, just above its 20‑day SMA (14.72) but below the 50‑day SMA (15.59), indicating a tentative short‑term bounce while longer‑term momentum remains neutral. The RSI sits at 48.9 and the MACD histogram is positive, giving a modest bullish technical signal, yet the stock sits near its calculated support of CNY 13.46 and faces a wide resistance band near CNY 16.30. On the fundamentals side, the current PE of 42.7 far exceeds the industry average of 34, suggesting the stock is overvalued at present, although the forward PE of 11.9 points to a potential earnings upside if the company can reverse its negative operating margin (-10.9%) and improve cash flow. The balance sheet is strained, with a debt‑to‑equity ratio of 87.7% and total debt (CNY 20.6 bn) outstripping cash (CNY 14.7 bn), while free cash flow is zero, raising questions about the sustainability of the 0.6% dividend. Volatility is high (57% 30‑day) and the beta is low (≈0.4), meaning price swings are pronounced but not strongly correlated with market moves, adding to overall risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical bullish hint from MACD but price near support
  • High short‑term volatility
  • Weak operating margins and zero free cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward PE suggests earnings improvement potential
  • Modest dividend yield with reasonable payout ratio
  • Continued leverage concerns and debt servicing risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term growth of the solar industry and parent company backing
  • Potential earnings turnaround reflected in forward EPS
  • Improving valuation metrics if profitability recovers

Key Metrics & Analysis

Financial Health

Revenue Growth-25.00%
Profit Margin2.54%
P/E Ratio42.7
ROE4.41%
Debt/Equity87.72
P/B Ratio2.3
Industry P/E34.2

Technical Analysis

TrendNeutral
RSI48.9
SupportCN¥13.46
ResistanceCN¥16.30
MA 20CN¥14.72
MA 50CN¥15.59
MA 200CN¥13.02
MACDBullish
VolumeIncreasing
Fear & Greed Index77.95

Valuation

GradeOvervalued
TypeBlend
Dividend Yield0.60%

Risk Assessment

Beta0.38
Volatility57.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.